Term
WBC Normal values (cells/mm3) |
|
Definition
|
|
Term
WBC Bacterial values (cells/mm3) |
|
Definition
|
|
Term
Cerebral Spinal Fluid Normal Differential % |
|
Definition
|
|
Term
Cerebral Spinal FLuid Bacterial Differential % |
|
Definition
> or equal to 80 polymorphonuclear neutrophils (PMNs) |
|
|
Term
Protein (mg/dL) Normal value |
|
Definition
|
|
Term
Protein (mg/dL) Bacterial values |
|
Definition
|
|
Term
Glucose (mg/dL) Normal serum value |
|
Definition
|
|
Term
Glucose (mg/dL) Bacterial value |
|
Definition
40% decrease (a nutrient) (<60% serum value) |
|
|
Term
1 month - 4 years old most likely organism for bacterial meningitis |
|
Definition
S. Pneumoniae, N meningiditis, H. influenzae |
|
|
Term
1 month- 4 years old Empirical Therapy for Bacterial Meningitis |
|
Definition
Vancomycin and cefotaxime or ceftriaxone |
|
|
Term
Newborn- 1 month most likely organism for bacterial meningitis |
|
Definition
Group B Streptococcus, Gram-negative enterics, Listeria monocytogenes |
|
|
Term
Newborn-1 month empirical therapy for bacterial meningitis |
|
Definition
Ampicillin plus cefotaxime or ceftriaxone or aminoglycoside |
|
|
Term
5-29 years most likely organism for bacterial meningitis |
|
Definition
N. meningiditis, S. pneumoniae, H. influenzae |
|
|
Term
5-29 years old empirical therapy for bacterial meningitis |
|
Definition
Vancomycin and cefotaxime or ceftriaxone |
|
|
Term
30-60 years most likely organism for bacterial meningitis |
|
Definition
S. pneumoniae, N. meningiditis |
|
|
Term
30-60 years empirical therapy for bacterial meningitis |
|
Definition
Vancomycin and cefotaxime or ceftriaxone |
|
|
Term
> 60 years old most likely organism for bacterial meningitis |
|
Definition
S. pneumoniae, Gram-negative enterics, L. monocytogenes |
|
|
Term
> 60 years old empirical therapy for bacterial meningitis |
|
Definition
Vancomycin plus ampicillin plus cefotaxime or ceftriaxone |
|
|
Term
Streptococcus pneumoniae: Penicillin- susceptible (abx 1st choice) |
|
Definition
Penicillin G or ampicillin (A-III) |
|
|
Term
Streptococcus pneumoniae: Penicillin-intermediate (Abx 1st choice) |
|
Definition
Cefotaxime or ceftriaxone (A-III) |
|
|
Term
Streptococcus pneumoniae: Penicillin- resistant (Abx 1st choice) |
|
Definition
Vancomycin plus cefotaxime or ceftriaxone (A-III) |
|
|
Term
Streptococcus pneumoniae: Penicillin-susceptible (alternative antibiotics) |
|
Definition
Cefotaxime (A-III), ceftriaxone (A-III), chloramphenicol (A-III) |
|
|
Term
Streptococcus pneumoniae: Penicillin-intermediate (alternative antibiotics) |
|
Definition
Cefepime (B-II), meropenem (B-II), moxifloxacin (B-II), linezolid (C-III) |
|
|
Term
Streptococcus pneumoniae: Penicillin-resistant (alternative antibiotics) |
|
Definition
Cefepime (B-II), meropenem (B-II), moxifloxacin (B-II), linezolid (C-III) |
|
|
Term
Streptococcus pneumoniae meningitis Txt Duration |
|
Definition
|
|
Term
Group B Streptococcus (abx of first choice) |
|
Definition
penicillin G or ampicillin +/- gentamicin (A-III) |
|
|
Term
Group B Streptococcus (alternative abx) |
|
Definition
Cefepime (B-III), meropenem (B-III), chloramphenicol (B-III) |
|
|
Term
Staph aureus Methicillin-susceptible (1st choice abx) |
|
Definition
nafcillin or oxacillin (A-III) |
|
|
Term
Staph aureus methicillin resistant (1st choice abx) |
|
Definition
|
|
Term
staph aureus methicillin-susceptible (alternative abx) |
|
Definition
vancomycin (A-iii), meropenem (B-III) |
|
|
Term
staph aureus methicillin-resistant (alternative abx) |
|
Definition
trimethoprim-sulfamethoxazole (A-III) linezolid (B-III) |
|
|
Term
staph epidermidis (abx 1st choice) |
|
Definition
|
|
Term
staph epidermidis (alternative abx) |
|
Definition
|
|
Term
Listeria monocytogenes (abx 1st choice) |
|
Definition
Penicillin G or ampicillin +/- gentamicin (A-III) |
|
|
Term
Listeria monocytogenes (alternative abx) |
|
Definition
trimethoprim-sulfamethoxazole (A-III), meropenem (B-III) |
|
|
Term
Group B Streptococcus meningitis Txt Duration |
|
Definition
|
|
Term
Staph aureus meningitis Txt Duration |
|
Definition
|
|
Term
Staph epidermidis meningitis Txt Duration |
|
Definition
|
|
Term
Listeria monocytogenes meningitis Txt Duration |
|
Definition
|
|
Term
Neisseria meningitis = memingococcus Penicillin susceptible- most (abx 1st choice) |
|
Definition
Penicillin G or ampicillin |
|
|
Term
Neisseria meningitis = memingococcus Penicillin-susceptible-most (alternative abx) |
|
Definition
Cefotaxime, ceftriaxone, chloramphenicol |
|
|
Term
Neisseria meningitis = memingococcus Penicillin-resistant (abx 1st choice) |
|
Definition
Cefotaxime or ceftriaxone |
|
|
Term
Neisseria meningitis = memingococcus Penicillin-resistant (alternative abx) |
|
Definition
chloramphenicol, meropenem, fluoroquinolone |
|
|
Term
Haemophilus influenzae: beta lactamase negative (Abx 1st choice) |
|
Definition
|
|
Term
Haemophilus influenzae: beta lactamase negative (abx alternative) |
|
Definition
cefotaxime, ceftriaxone, chloramphenicol, cefepime, fluoroquinolone |
|
|
Term
Haemophilus influenzae: beta lactamase positive (Abx 1st choice) |
|
Definition
cefotaxime or ceftriaxone |
|
|
Term
Haemophilus influenzae: beta lactamase positive (abx alternatives) |
|
Definition
cefepime, fluoroquinolone, chloramphenicol |
|
|
Term
Enterobacteriaceae (1st choice abx) |
|
Definition
cefotaxime or ceftriaxone |
|
|
Term
Enterobacteriaceae (abx alternatives) |
|
Definition
cefepime, fluoroquinolone, meropenem, aztreonam |
|
|
Term
Pseudomonas aeruginose (1st choice abx) |
|
Definition
cefepime or ceftazidime +/- tobramycin |
|
|
Term
Pseudomonas aeruginose (abx alternative) |
|
Definition
ciprofloxacin, meropenem, piperacillin plus tobramycin, colistin sulfomethate, aztreonam |
|
|
Term
Neisseria meningitis txt duration |
|
Definition
|
|
Term
haemophilus influenzae txt duration |
|
Definition
|
|
Term
enterobacteriaceae txt duration |
|
Definition
|
|
Term
pseudomonas aeruginosa txt duration |
|
Definition
|
|
Term
most potent steroid- good for decreasing cerebral swelling- lessened permanent mental retardation in pts with meningitis due to swelling back in the days; may not be as beneficial anymore, it is now used for only the first 24 hours |
|
Definition
|
|